Alignment Healthcare, Inc. (NASDAQ:ALHC - Get Free Report) CFO Robert Thomas Freeman sold 250,000 shares of the stock in a transaction dated Tuesday, March 4th. The stock was sold at an average price of $15.58, for a total value of $3,895,000.00. Following the sale, the chief financial officer now owns 1,635,849 shares of the company's stock, valued at approximately $25,486,527.42. The trade was a 13.26 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink.
Robert Thomas Freeman also recently made the following trade(s):
- On Thursday, March 6th, Robert Thomas Freeman sold 218,295 shares of Alignment Healthcare stock. The stock was sold at an average price of $15.53, for a total value of $3,390,121.35.
Alignment Healthcare Stock Up 0.9 %
ALHC stock traded up $0.13 during midday trading on Monday, hitting $15.02. The company's stock had a trading volume of 2,232,665 shares, compared to its average volume of 2,080,941. The firm has a 50-day simple moving average of $13.97 and a 200-day simple moving average of $12.23. The company has a quick ratio of 1.60, a current ratio of 1.60 and a debt-to-equity ratio of 1.82. The firm has a market capitalization of $2.88 billion, a P/E ratio of -19.51 and a beta of 1.49. Alignment Healthcare, Inc. has a 52-week low of $4.46 and a 52-week high of $16.25.
Institutional Inflows and Outflows
Several large investors have recently modified their holdings of the stock. Creative Planning boosted its holdings in shares of Alignment Healthcare by 20.0% in the third quarter. Creative Planning now owns 12,442 shares of the company's stock valued at $147,000 after acquiring an additional 2,072 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its holdings in shares of Alignment Healthcare by 3.9% in the fourth quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 56,963 shares of the company's stock worth $641,000 after acquiring an additional 2,154 shares during the last quarter. Rhumbline Advisers lifted its stake in shares of Alignment Healthcare by 2.2% during the fourth quarter. Rhumbline Advisers now owns 135,704 shares of the company's stock valued at $1,527,000 after buying an additional 2,937 shares during the period. MetLife Investment Management LLC grew its position in shares of Alignment Healthcare by 5.6% in the fourth quarter. MetLife Investment Management LLC now owns 61,344 shares of the company's stock valued at $690,000 after purchasing an additional 3,256 shares during the period. Finally, Alliancebernstein L.P. lifted its position in Alignment Healthcare by 2.8% during the fourth quarter. Alliancebernstein L.P. now owns 119,440 shares of the company's stock worth $1,344,000 after buying an additional 3,300 shares during the period. Institutional investors and hedge funds own 86.19% of the company's stock.
Analyst Ratings Changes
A number of brokerages recently weighed in on ALHC. JPMorgan Chase & Co. raised their target price on shares of Alignment Healthcare from $14.00 to $17.00 and gave the company a "neutral" rating in a research note on Thursday. Bank of America upped their price target on Alignment Healthcare from $15.50 to $18.50 and gave the stock a "buy" rating in a research note on Tuesday, March 4th. Stifel Nicolaus increased their price target on Alignment Healthcare from $16.00 to $18.00 and gave the company a "buy" rating in a report on Friday, February 28th. William Blair reissued an "outperform" rating on shares of Alignment Healthcare in a report on Friday, February 28th. Finally, Barclays lifted their price target on Alignment Healthcare from $8.00 to $9.00 and gave the stock an "underweight" rating in a research report on Friday, February 28th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating, seven have issued a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average target price of $14.83.
Check Out Our Latest Research Report on Alignment Healthcare
About Alignment Healthcare
(
Get Free Report)
Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.
Featured Articles
Before you consider Alignment Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Alignment Healthcare wasn't on the list.
While Alignment Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for April 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
